Whittier Trust’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-35
| Closed | -$253 | – | 1620 |
|
|
2023
Q3 | $253 | Buy |
+35
| New | +$280 | ﹤0.01% | 1620 |
|
|
2022
Q2 | – | Sell |
-3
| Closed | – | – | 1741 |
|
|
2022
Q1 | $0 | Buy |
+3
| New | +$268 | ﹤0.01% | 1737 |
|
|
2021
Q3 | – | Sell |
-505
| Closed | -$107K | – | 1552 |
|
|
2021
Q2 | $107K | Sell |
505
-357
| -41% | -$65.4K | ﹤0.01% | 786 |
|
|
2021
Q1 | $156K | Buy |
862
+787
| +1,049% | +$157K | ﹤0.01% | 684 |
|
|
2020
Q4 | $8K | Hold |
75
| – | – | ﹤0.01% | 1181 |
|
|
2020
Q3 | $8K | Hold |
75
| – | – | ﹤0.01% | 1164 |
|
|
2020
Q2 | $6K | Hold |
75
| – | – | ﹤0.01% | 1139 |
|
|
2020
Q1 | $1K | Hold |
75
| – | – | ﹤0.01% | 1405 |
|
|
2019
Q4 | $0 | Sell |
75
-50
| -40% | -$217 | ﹤0.01% | 1573 |
|
|
2019
Q3 | $1K | Sell |
125
-50
| -29% | -$274 | ﹤0.01% | 1469 |
|
|
2019
Q2 | $1K | Hold |
175
| – | – | ﹤0.01% | 1306 |
|
|
2019
Q1 | $2K | Hold |
175
| – | – | ﹤0.01% | 1219 |
|
|
2018
Q4 | $6K | Sell |
175
-100
| -36% | -$3.88K | ﹤0.01% | 1154 |
|
|
2018
Q3 | $10K | Hold |
275
| – | – | ﹤0.01% | 1044 |
|
|
2018
Q2 | $7K | Hold |
275
| – | – | ﹤0.01% | 1062 |
|
|
2018
Q1 | $11K | Hold |
275
| – | – | ﹤0.01% | 1034 |
|
|
2017
Q4 | $7K | Sell |
275
-150
| -35% | -$3.66K | ﹤0.01% | 1088 |
|
|
2017
Q3 | $10K | Hold |
425
| – | – | ﹤0.01% | 1026 |
|
|
2017
Q2 | $10K | Hold |
425
| – | – | ﹤0.01% | 995 |
|
|
2017
Q1 | $11K | Hold |
425
| – | – | ﹤0.01% | 987 |
|
|
2016
Q4 | $11K | Hold |
425
| – | – | ﹤0.01% | 960 |
|
|
2016
Q3 | $18K | Hold |
425
| – | – | ﹤0.01% | 888 |
|
|
2016
Q2 | $62K | Hold |
425
| – | – | ﹤0.01% | 676 |
|
|
2016
Q1 | $44K | Buy |
425
+50
| +13% | +$5.36K | ﹤0.01% | 734 |
|
|
2015
Q4 | $63K | Sell |
375
-75
| -17% | -$11.5K | ﹤0.01% | 680 |
|
|
2015
Q3 | $64K | Buy |
450
+100
| +29% | +$22.4K | ﹤0.01% | 662 |
|
|
2015
Q2 | $78K | Buy |
350
+195
| +126% | +$34.3K | ﹤0.01% | 650 |
|
|
2015
Q1 | $26K | Buy |
155
+80
| +107% | +$13K | ﹤0.01% | 830 |
|
|
2014
Q4 | $9K | Buy |
+75
| New | +$7.84K | ﹤0.01% | 892 |
|
Other funds holding NVAX
SCM
Whittier Trust's NVAX Position: Q4 2023 in Review
Whittier Trust sold out of Novavax (NVAX) in Q4 2023, closing a stake of 35 shares — an estimated $253 sold.
Whittier Trust first reported a position in NVAX in Q4 2014 and held it in 29 quarters. The position peaked at $156K in Q1 2021. 199 funds tracked by Wall St. Rank hold NVAX as of Q4 2023.
- Whittier Trust reported no remaining Novavax position as of Q4 2023 after selling out during the quarter.
- Whittier Trust sold 35 Novavax shares in Q4 2023, an estimated $253.
- Whittier Trust first reported a position in Novavax in Q4 2014 and held it in 29 quarters.
- Whittier Trust's Novavax position peaked at $156K in Q1 2021.
- 199 funds tracked by Wall St. Rank held Novavax as of Q4 2023.
Based on Whittier Trust's 13F filing for Q4 2023, filed 11 Jan 2024.